secwatch.observer — SEC 8-K summary
======================================

Issuer:     Olema Pharmaceuticals, Inc. (OLMA)
CIK:        0001750284
Form:       8-K
Filed at:   2023-06-21T23:59:59+00:00
Accession:  0001558370-23-011291
Event type: other
Sentiment:  neutral
Materiality: 0.15
Item codes: 5.07
LLM model:  deepseek-v4-flash:cloud@v2

Olema holds annual meeting; stockholders elect three directors, approve say-on-pay, ratify E&Y auditor
--------------------------------------------------------------------------------

- Sean P. Bohen, Yi Larson, and Andrew Rappaport elected as Class III directors through 2026 with votes 23.5M, 18.0M, and 23.7M for respectively.
- Advisory vote on executive compensation approved: 18.7M for, 1.9M against, 5.0M abstain, 5.8M broker non-votes.
- Ratification of Ernst & Young as independent auditor for FY2023 approved: 30.9M for, 10k against, 540k abstain.
- Broker non-votes of 5.8M shares present on director and compensation proposals.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1750284/000155837023011291/0001558370-23-011291-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1750284/000155837023011291/olma-20230615x8k.htm
  HTML page:      https://secwatch.observer/filing/0001558370-23-011291

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer